> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 1st Patient Engagement Committee Meeting Set
- URL: https://www.fdaweb.com/1st-patient-engagement-committee-meeting-set/
- Published: 2017-07-25T12:00:00.000Z
- Updated: 2026-09-14T22:36:12.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5139213

The FDA Patient Engagement Advisory Committee will hold its inaugural meeting 10/11-12\. In an *FDA Voice* blog [post](https://blogs.fda.gov/fdavoice/index.php/2017/07/fda-sets-inaugural-meeting-of-first-ever-patient-engagement-advisory-committee/?ref=fdaweb.com), CDRH director **Jeffrey Shuren** and assistant director for strategic programs **Kathryn O’Callaghan** write that this is the first time an FDA advisory committee will focus on patient-related issues. The topic for this session, they say, will be the challenges of clinical trial design, conduct, and reporting as identified by patients.

“FDA chose this subject,” the two write, “because patients often have concerns about participating in clinical trials or drop out once they have enrolled in a trial. Inconsistent or minimal participation in clinical trials can make it difficult to reach reliable conclusions or to determine the level of benefit for patients. It also can take longer to bring technological advances to the patients who need them.”

Shuren and O’Callaghan say the committee is a forum for the voice of patients. It will be asked to advise on complex issues related to medical devices and their impact on patients. “The goal of PEAC is to better understand and integrate patient perspectives into our oversight, to improve communications with patients about benefits, risks, and clinical outcomes related to medical devices, and to identify new approaches, unforeseen risks or barriers, and unintended consequences from the use of medical devices,” they say.